Allele burden expansion in JAK2 (V617F) and CALR-mutated myeloproliferative neoplasms predicts disease progression and is associated with anagrelide treatment.
- DOI
- 10.1002/hem3.70460
- Published
- 2026 Sep
- Container
- HemaSphere
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/hem3.70460,
title = {Allele burden expansion in JAK2 (V617F) and CALR-mutated myeloproliferative neoplasms predicts disease progression and is associated with anagrelide treatment.},
author = {Ng ZY and Cottin L and Demoy M and Paz DL and Orvain C and Lambert WC and Ianotto JC and Lippert E and Ross DM and Iarossi D and Khan A and Lock D and Truong C and Laribi K and Yang YF and Gagnon LL and Ugo V and Harrison CN and O'Sullivan J},
year = {2026},
journal = {HemaSphere},
doi = {10.1002/hem3.70460},
url = {https://doi.org/10.1002/hem3.70460}
}RIS
TY - JOUR TI - Allele burden expansion in JAK2 (V617F) and CALR-mutated myeloproliferative neoplasms predicts disease progression and is associated with anagrelide treatment. AU - Ng ZY AU - Cottin L AU - Demoy M AU - Paz DL AU - Orvain C AU - Lambert WC AU - Ianotto JC AU - Lippert E AU - Ross DM AU - Iarossi D AU - Khan A AU - Lock D AU - Truong C AU - Laribi K AU - Yang YF AU - Gagnon LL AU - Ugo V AU - Harrison CN AU - O'Sullivan J PY - 2026 JO - HemaSphere DO - 10.1002/hem3.70460 UR - https://doi.org/10.1002/hem3.70460 ER -
APA
ZY, N., L, C., M, D., DL, P., C, O., WC, L., JC, I., E, L., DM, R., D, I., A, K., D, L., C, T., K, L., YF, Y., LL, G., V, U., CN, H., & J, O. (2026). Allele burden expansion in JAK2 (V617F) and CALR-mutated myeloproliferative neoplasms predicts disease progression and is associated with anagrelide treatment.. HemaSphere. https://doi.org/10.1002/hem3.70460
Source records
- pubmed · retrieved 2026-09-25T00:48:44.472Z